Overview

Determining the Effect of Abiraterone on the Metabolism of Oxycodone in Men With Prostate Cancer (the ENABLE Study)

Status:
RECRUITING
Trial end date:
2026-01-30
Target enrollment:
Participant gender:
Summary
Prostate cancer often leads to bone metastases, which require adequate pain management with opioids such as oxycodone. This study investigates whether abiraterone - a drug used in the treatment of prostate cancer - affects the pharmacokinetics of oxycodone in order to improve pain management.
Phase:
PHASE4
Details
Lead Sponsor:
Deventer Ziekenhuis
Treatments:
Abiraterone Acetate
Oxycodone